Results 11 to 20 of about 12,826 (224)

Cardiovascular Risk/Benefit Profile of MHT [PDF]

Medicina, 2019
Background and Objectives: Data emerging from the Women’s Health Initiative (WHI) study point toward an association between menopausal hormone therapy (MHT) and cardiovascular (CV) risk. However, post hoc subgroup analyses stratifying participants according to their age and time since menopause, have opened the way to a better understanding of the ...
Villa P., Amar I. D., Shachor M., Cipolla C., Ingravalle F., Scambia G.   +5 more
core   +6 more sources

The impact of menopausal hormone therapy (MHT) on cardiac structure and function: Insights from the UK Biobank imaging enhancement study. [PDF]

PLoS ONE, 2018
BackgroundThe effect of menopausal hormone therapy (MHT)-previously known as hormone replacement therapy-on cardiovascular health remains unclear and controversial.
Mihir M Sanghvi, Nay Aung, Jackie A Cooper, José Miguel Paiva, Aaron M Lee, Filip Zemrak, Kenneth Fung, Ross J Thomson, Elena Lukaschuk, Valentina Carapella, Young Jin Kim, Nicholas C Harvey, Stefan K Piechnik, Stefan Neubauer, Steffen E Petersen   +14 more
doaj   +3 more sources

Menopause Hormone Therapy in Women With Cardiovascular Risk Factors or Established Ischemic Heart Disease: A Joint FIGO and WHF Position Paper. [PDF]

Glob Heart
Integrated approach to menopausal hormone therapy in women with cardiovascular risk factors or established ischemic heart disease, from early treatment initiation and risk stratification to individualized therapy, multidisciplinary follow‐up, and health‐system recommendations.
Benedetto C, Gulati M, Khadilkar SS, Maas AHEM, Frezet F, de Oliveira GMM, Genazzani AR, Divakar H, Poppas A, International Federation of Gynecology and Obstetrics (FIGO) and World Heart Federation (WHF).   +9 more
europepmc   +2 more sources

Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions

, 2022
Practice Guideline aceptada y apoyada por 21 sociedades científicas de todo el mundoThis project aims to develop eligibility criteria for menopausal hormone therapy (MHT).
Calaf, Joaquín, Mendoza, Nicolás, Coronado Martín, Pluvio Jesús, Mendoza Ladrón De Guevara, Nicolás   +3 more
core   +1 more source

Role of menopausal hormone therapy in the issues of preventing cardiovascular disorders in women in their post-reproductive stage

Клинический разбор в общей медицине, 2023
Cardiovascular disorders (CVD) in female population are the main cause of mortality, and an increase in the prevalence of myocardial infarction among women is observed in the recent decades, in contrast to the male population showing a decrease in this ...
Madina I. Mazitova, Rezeda R. Mardieva, Karina V. Faustova   +2 more
doaj   +1 more source

Kartläggning av användningsmönstret av Menopausal Hormone Therapy (MHT)

, 2021
Background Menopausal hormone therapy (MHT) is used to treat menopausal symptoms. The use of MHT decreased after the Women's Health Initiative (WHI) study which proved an increased risk of stroke and breast cancer.
Khorsheed, Sarah
core   +2 more sources

Rola łańcuchów przemysłowych w kształtowaniu aktywności innowacyjnej przedsiębiorstw średnio wysokiej i wysokiej techniki w Polsce

Problemy Zarządzania, 2015
The article presents the results of a study which aims to compare the effect of the number of industrial vertical linkages and participation in the supply chain on innovation activity of medium-high and high technology industries in Poland.
Piotr Dzikowski
doaj   +1 more source

A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations [PDF]

Journal of Clinical and Diagnostic Research, 2016
Introduction: Rapid identification of carbapenemase producing organisms is of great importance for timely detection, treatment and implementation of control measures to prevent the spread.
Agila Kumari Pragasam, Rani Diana Sahni, Shalini Anandan, Archa Sharma, Radha Gopi, Noorjahan Hadibasha, Priya Gunasekaran, Balaji Veeraraghavan   +7 more
doaj   +1 more source

Algorithms for prescribing menopausal hormone therapy in different periods of menopause

Репродуктивная эндокринология, 2022
Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause. MHT, initiated in women during the “therapeutic window” to relieve symptoms of estrogens deficiency and prevent or treat
T.F. Tatarchuk, N.F. Zakharenko, S.I. Reheda, T.I. Kvasha   +3 more
doaj   +1 more source

Depression in postmenopause: interdisciplinary approach in management and perspectives for rehabilitation

Акушерство, гинекология и репродукция, 2022
Surgical and natural menopause is often associated with depression symptoms. Along with the postpartum period, perimenopause is a “window of vulnerability” for depression development, because decline in estrogen level accounts for extinction of ...
D. V. Blinov, E. S. Akarachkova, D. M. Ampilogova, E. M. Dzhobava, V. I. Tsibizova, A. G. Solopova, N. V. Pavlova, D. I. Korabelnikov, D. A. Petrenko   +8 more
doaj   +1 more source